Patents by Inventor Peter Oeltgen

Peter Oeltgen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20050222038
    Abstract: A compound and method for using the compound to reduce injury associated with ischemia and reperfusion of mammalian organs such as the heart. The compound, either Deltorphin A and/or Dermorphin H, may be administered as part of a preconditioning strategy which reduces the extent of injury and improves organ function following cessation and restoration of blood flow. The compound may be used in preparation for planned ischemia or in a prophylactic manner in anticipation of further ischemic events.
    Type: Application
    Filed: May 31, 2005
    Publication date: October 6, 2005
    Applicants: UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION
    Inventors: Peter Oeltgen, Paul Bishop, Mark Kindy, Juan Sanchez
  • Publication number: 20050164942
    Abstract: A method of modulating cytokine mediated hepatic injury by administering compound-D SEQ ID NO:1 to a mammal. A concentration of the compound in the range of about 0.5 mg/kg to about 20 mg/kg in a physiologically acceptable formulation blocks a cytokine cascade. A therapeutic method of modulating cytokine mediated acute inflammatory, trauma induced and toxin induced hepatic injury, particularly via tumor necrosis factor modulation, is thus disclosed.
    Type: Application
    Filed: March 22, 2005
    Publication date: July 28, 2005
    Applicants: UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, ZymoGenetics
    Inventors: Peter Oeltgen, Paul Bishop, Craig McClain, Shirish Barve